Australien - Englisch - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - donepezil hydrochloride, quantity: 5 mg - tablet, film coated - excipient ingredients: macrogol 6000; maize starch; lactose monohydrate; titanium dioxide; purified talc; microcrystalline cellulose; sodium stearylfumarate; hypromellose; hyprolose - donepezil is indicated for the treatment of mild, moderate and severe alzheimer's disease.

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

alembic pharmaceuticals limited - donepezil hydrochloride (unii: 3o2t2pj89d) (donepezil - unii:8ssc91326p) - donepezil hydrochloride 5 mg - donepezil hydrochloride is indicated for the treatment of dementia of the alzheimer’s type. efficacy has been demonstrated in patients with mild, moderate, and severe alzheimer's disease. donepezil hydrochlorideis contraindicated in patients with known hypersensitivity to donepezil hydrochloride or to piperidine derivatives. pregnancy category c: there are no adequate or well-controlled studies in pregnant women. donepezil hydrochloride should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. oral administration of donepezil to pregnant rats and rabbits during the period of organogenesis did not produce any teratogenic effects at doses up to 16 mg/kg/day and 10 mg/kg/day (approximately 7 times the mrhd on a mg/m2 basis), respectively. oral administration of donepezil (1, 3, 10 mg/kg/day) to rats during late gestation and throughout lactation to weaning produced an increase in stillbirths and reduced offspring survival through postpartum day 4 at the highes

Kanada - Englisch - Health Canada

apotex inc - donepezil hydrochloride (donepezil hydrochloride monohydrate) - tablet - 5mg - donepezil hydrochloride (donepezil hydrochloride monohydrate) 5mg - parasympathomemetic (cholinergic) agents

Kanada - Englisch - Health Canada

apotex inc - donepezil hydrochloride (donepezil hydrochloride monohydrate) - tablet - 10mg - donepezil hydrochloride (donepezil hydrochloride monohydrate) 10mg - parasympathomemetic (cholinergic) agents

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - donepezil hydrochloride -

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - donepezil hydrochloride -

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - donepezil hydrochloride -

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - donepezil hydrochloride -

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

mckesson corporation dba sky packaging - donepezil hydrochloride (unii: 3o2t2pj89d) (donepezil - unii:8ssc91326p) - donepezil hydrochloride 5 mg - donepezil hydrochloride tablets are indicated for the treatment of dementia of the alzheimer's type. efficacy has been demonstrated in patients with mild, moderate, and severe alzheimer's disease. donepezil hydrochloride is contraindicated in patients with known hypersensitivity to donepezil hydrochloride or to piperidine derivatives. risk summary there are no adequate data on the developmental risks associated with the use of donepezil hydrochloride in pregnant women. in animal studies, developmental toxicity was not observed when donepezil was administered to pregnant rats and rabbits during organogenesis, but administration to rats during the latter part of pregnancy and throughout lactation resulted in increased stillbirths and decreased offspring survival at clinically relevant doses [see data ]. in the u.s. general population, the estimated background risks of major birth defects and miscarriage in clinically recognized pregnancies are 2% to 4% and 15% to 20%, respectively. the background risks of major

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

dr. reddys laboratories limited - donepezil hydrochloride (unii: 3o2t2pj89d) (donepezil - unii:8ssc91326p) - donepezil hydrochloride 23 mg - donepezil hydrochloride tablets are indicated for the treatment of dementia of the alzheimer’s type. efficacy has been demonstrated in patients with mild, moderate, and severe alzheimer’s disease. donepezil hydrochloride tablets are contraindicated in patients with known hypersensitivity to donepezil hydrochloride or to piperidine derivatives. risk summary there are no adequate data on the developmental risks associated with the use of donepezil in pregnant women. in animal studies, developmental toxicity was not observed when donepezil was administered to pregnant rats and rabbits during organogenesis, but administration to rats during the latter part of pregnancy and throughout lactation resulted in increased stillbirths and decreased offspring survival at clinically relevant doses [see data]. in the u.s. general population, the estimated background risks of major birth defects and miscarriage in clinically recognized pregnancies are 2% to 4% and 15% to 20%, respectively. the background risks of major birth